Vitrectomy for severe diabetic retinopathy
Part of Eyes & vision clinical trials.
This study looks at how well surgery called vitrectomy works for people with severe nonproliferative diabetic retinopathy (NPDR), a condition where high blood sugar damages the retina. The trial aims to see if this surgery can improve vision and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have severe nonproliferative diabetic retinopathy, which means you have certain changes in your retina like bleeding spots or abnormal blood vessels.
- Your vision in the study eye is between 20/400 and 20/32 (a certain level of vision loss).
- You have not had laser treatment or surgery on your eye (except cataract surgery) before.
- You have not had injections into the eye or certain medications in the last 3 months.
- You are willing to sign a consent form and follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an experimental eye drop can slow or treat early-stage diabetic retinopathy. If you have diabetes-related vision changes, this treatment might help prevent the condition from getting worse.
This trial compares two treatments for early diabetic retinopathy—a condition where high blood sugar damages blood vessels in the eye. Researchers want to see if removing fluid from inside the eye (vitrectomy) works better than laser treatment to prevent vision loss.
This trial tests a new medicine, RRG001, given after vitrectomy surgery for severe diabetic eye disease. It aims to see if the drug is safe and helps prevent vision loss.
This trial is testing a new laser treatment pattern for people with diabetic eye disease (proliferative diabetic retinopathy) to see if it works better than the standard approach. If you have this condition and want a less invasive treatment option, this study might be a good fit.
This trial tests whether giving bevacizumab (a medicine that slows abnormal blood vessel growth) right after vitrectomy (a surgery to remove blood or scar tissue from the eye) can help people with advanced diabetic eye disease. The goal is to improve vision and reduce the need for more treatments.
This study compares two approaches to treat advanced diabetic eye disease (proliferative diabetic retinopathy): injections of faricimab plus laser, versus surgery (vitrectomy) with laser. It is for people with diabetes who need treatment for PDR and still have relatively good vision (20/100 or better) in the affected eye.
Hear when a new Non Proliferative Diabetic Retinopathy(NPDR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.